| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/04/2001 | WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis |
| 10/04/2001 | WO2001019373A3 Methods and compositions for modulating responsiveness to corticosteroids |
| 10/04/2001 | WO2001019335A3 Composition to be administered through mucous membrane |
| 10/04/2001 | WO2001018208A3 Interferon induced polynucleotides and proteins encoded thereby |
| 10/04/2001 | WO2001016319A3 Compositions and methods for the treatment of immune related diseases |
| 10/04/2001 | WO2001008701A3 Invasive bacteria based viral vaccines |
| 10/04/2001 | WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof |
| 10/04/2001 | WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 10/04/2001 | WO2000078343A8 Method for treating chronic hbv infection |
| 10/04/2001 | WO2000051632A3 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE |
| 10/04/2001 | WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 10/04/2001 | WO2000043515A3 Methods of monitoring hiv drug resistance |
| 10/04/2001 | WO2000043039A9 Vaccine-mediated treatment of neurological disorders |
| 10/04/2001 | WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor |
| 10/04/2001 | WO2000039310A9 Rubredoxin fusion proteins, protein expression system and methods |
| 10/04/2001 | WO2000032634A9 Humanized antibodies to gamma-interferon |
| 10/04/2001 | WO2000021556A9 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 10/04/2001 | WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto |
| 10/04/2001 | US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias |
| 10/04/2001 | US20010027184 Serine/threonine protein kinase (H-SGK2) |
| 10/04/2001 | US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab |
| 10/04/2001 | US20010026938 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines |
| 10/04/2001 | US20010026937 Culturing population of peripheral blood or bone marrow mononuclear cells in interleukin-4, granulocyte macrophage colony stimulating factor, and culture medium comprising insulin, transferrin, linoleic acid, oleic acid, palmitic acid |
| 10/04/2001 | US20010026932 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 10/04/2001 | US20010026800 Delivering an immunogen to a preselected region of the gastrointestinal tract |
| 10/04/2001 | US20010026798 Methods of enhancing activity of vaccines and vaccine compositions |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 10/04/2001 | EP1138334A2 Pretargeting methods and compounds |
| 10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137786A1 Virus coat protein/receptor chimeras and methods of use |
| 10/04/2001 | EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137778A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 10/04/2001 | EP1137777A2 Novel compounds derived from neisseria meningitidis |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137770A2 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137766A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 10/04/2001 | EP1137759A2 Live attenuated venezuelan equine encephalitis vaccine |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP1137665A1 Cark protein and nucleic acid molecules and uses therefor |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137436A1 Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 10/04/2001 | EP1137435A2 Adjuvant comprising pulmonary surfactant |
| 10/04/2001 | EP1137434A2 New cancer treatments |
| 10/04/2001 | EP1137433A2 Pharmaceutical compositions containing protein-disulfide isomerases |
| 10/04/2001 | EP1137422A2 Use of human prostate cell lines in cancer treatment |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0835132B1 Recombinant temperature sensitive mutants of influenza virus |
| 10/04/2001 | EP0802796B1 Chicken anaemia agent broiler vaccine |
| 10/04/2001 | EP0772632B1 T cell stimulating protein of pestivirus |
| 10/04/2001 | EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies |
| 10/04/2001 | CA2407036A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 10/04/2001 | CA2405502A1 Method of treating hepatitis delta viral infection |
| 10/04/2001 | CA2404964A1 Methods for detecting inflammation and inflammatory conditions |
| 10/04/2001 | CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents |
| 10/04/2001 | CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | CA2404461A1 Human g-protein coupled receptors |
| 10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/04/2001 | CA2404390A1 Methods of therapy for non-hodgkin's lymphoma using a combination of an antibody to cd20 and interleukin-2 |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404164A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | CA2404041A1 Methods for increasing a cytotoxic t lymphocyte response in vivo |
| 10/04/2001 | CA2403993A1 Proteins for use as carriers in conjugate vaccines |
| 10/04/2001 | CA2403984A1 Recombinant iron uptake proteins |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403764A1 Methods for immunostimulation using binding agents for the fc receptor of immunoglobulin a |
| 10/04/2001 | CA2402453A1 Compounds for targeting |
| 10/04/2001 | CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/04/2001 | CA2401249A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 10/03/2001 | CN1315998A Compositions and methods for therapy and diagnosis of prostate cancer |
| 10/03/2001 | CN1315967A Bifunctional antibodies and their use in targeting anti-tumour agents |
| 10/03/2001 | CN1315966A High-affinity antibodies |
| 10/03/2001 | CN1315872A Multivalent huma-bovine retavirus vaccine |
| 10/03/2001 | CN1315871A Live attenuated i(salmonella) vaccines to control avian pathogens |
| 10/03/2001 | CN1315870A Derivatives of pneumococcal choline binding proteins for vaccines |
| 10/03/2001 | CN1315869A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 10/03/2001 | CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 10/03/2001 | CN1315864A Powdery preparation for mucosal administration containing polymeric medicine |
| 10/02/2001 | US6297370 HCV genomic sequences for diagnostics and therapeutics |
| 10/02/2001 | US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 10/02/2001 | US6297361 Use of histidine decarboxylase immunoreactivity to detect human cancer |
| 10/02/2001 | US6297355 Preferential hepatitis viral protein; for the prevention, treament and detection of viral infection |
| 10/02/2001 | US6297219 Site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6297053 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/02/2001 | US6297050 Activation of t-cell response; mix peptides with sample containing t-cells and detect bound human leukocyte antigens |
| 10/02/2001 | US6297049 Methods and compositions for ameliorating the symptoms of sepsis |
| 10/02/2001 | US6297048 Expression vector for use in treatment of viral infections and caner |
| 10/02/2001 | US6297041 MN gene and protein |
| 10/02/2001 | US6297039 Amps from Streptococcus pneumoniae |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |